We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > Angelini

News List

Angelini Fine Chemicals Invests in Flow Chemistry & Micro-Reaction Technology contractpharma
May 13, 2021
A confluence of factors is driving the need for a paradigm shift in pharmaceutical manufacturing strategies in order to accelerate R&D pipeline to market.
EC approval for Ontozry pharmatimes
April 07, 2021
Angelini Pharma has announced European Commission (EC) approval for anti-seizure drug Ontozry (cenobamate).
Healthcare industry reported 70 deals worth $6.2 billion in January 2021: GlobalData expresspharma
February 08, 2021
In January 2021, the healthcare industry reported 70 deals worth $6.2 billion as compared to last 12-month average (January 2020 to December 2020) of 87 deals worth $17.1 billion.
Ovid, Angelini Pharma Enter Exclusive License Agreement contractpharma
July 14, 2020
To develop, manufacture and commercialize OV101 for the treatment of Angelman Syndrome in Europe.